Genelux Corporation (GNLX)
GNLX moved a median of -0.67% 30 minutes after news, and -1.19% by the close. How GNLX actually reacts to news — the realized, point-in-time move the market made, measured across 247 labeled events over the last three years with zero look-ahead.
GNLX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.34% | 52% | 246 |
| 30-min | -0.67% | 41% | 246 |
| 60-min | -0.97% | 38% | 246 |
| to close | -1.19% | 36% | 247 |
| Middle 50% of GNLX reactions | -2.43% to +1.13% |
|---|---|
| Median reaction (30-min) | -0.67% |
| Measured reactions | 247 |
Half of all Genelux Corporation news events land between -2.43% and +1.13% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How GNLX reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 16 | -2.58% | 31% | -0.38% |
| Rating reiterations | 21 | -1.36% | 38% | -1.64% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 3 further classes were observed with fewer than 10 measured events and are not published. See how GNLX ranks against every other measured name →
That’s how GNLX usually reacts — get an email when it moves on news →Email me when GNLX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to GNLX's baseline. Nothing else.
Recent GNLX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy | Press release | GlobeNewswire | +0.00% | -2.75% | |
| Form 10-Q GENELUX Corp For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.75% | -1.87% | |
| Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates | Press release | GlobeNewswire | +0.00% | +3.40% | |
| Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi-Vec in Ovarian Cancer | Press release | GlobeNewswire | -2.34% | +0.67% | |
| Form 8-K GENELUX Corp For: Jun 16 | SEC filing · Form 8-K | SEC EDGAR | -0.70% | +1.74% | |
| Form 10-Q GENELUX Corp For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -0.70% | +9.12% | |
| Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates | Press release | GlobeNewswire | -0.70% | +9.12% | |
| Form ARS GENELUX Corp For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -0.79% | -1.19% | |
| Form DEF 14A GENELUX Corp For: Apr 29 | SEC filing · Form DEF | SEC EDGAR | -0.79% | -1.19% | |
| Form DEFA14A GENELUX Corp | SEC filing · Form DEFA14A | SEC EDGAR | -0.79% | -1.19% | |
| Form 10-K GENELUX Corp For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -1.46% | +0.00% | |
| Form 8-K GENELUX Corp For: Mar 19 | SEC filing · Form 8-K | SEC EDGAR | -1.46% | +0.00% | |
| Form S-8 GENELUX Corp | SEC filing · Form S-8 | SEC EDGAR | -1.46% | +0.00% | |
| Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates | Press release | GlobeNewswire | -1.46% | +0.00% | |
| Genelux Corporation to Participate in Upcoming Conferences | Press release | GlobeNewswire | +0.00% | +2.75% | |
| Form 8-K GENELUX Corp For: Feb 02 | SEC filing · Form 8-K | SEC EDGAR | +0.37% | -0.37% | |
| Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners | Press release | GlobeNewswire | -2.24% | +2.24% | |
| Form 8-K GENELUX Corp For: Jan 08 | SEC filing · Form 8-K | SEC EDGAR | -0.69% | -2.78% | |
| Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock | Press release | GlobeNewswire | +2.41% | -6.21% | |
| Genelux Corporation Announces Proposed Public Offering of Common Stock | Press release | GlobeNewswire | +2.41% | -6.21% | |
| Form 8-K GENELUX Corp For: Jan 05 | SEC filing · Form 8-K | SEC EDGAR | +4.21% | -24.84% | |
| Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials | Press release | GlobeNewswire | +4.21% | -24.84% | |
| Form 8-K GENELUX Corp For: Dec 30 | SEC filing · Form 8-K | SEC EDGAR | +4.21% | -24.84% | |
| Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer | Press release | GlobeNewswire | +4.27% | +3.17% | |
| Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference | Press release | GlobeNewswire | +0.00% | +5.47% | |
| Form 10-Q GENELUX Corp For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -3.20% | -29.33% | |
| Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates | Press release | GlobeNewswire | -3.20% | -29.33% | |
| Form 8-K GENELUX Corp For: Aug 27 | SEC filing · Form 8-K | SEC EDGAR | +2.27% | +5.14% | |
| Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference | Press release | GlobeNewswire | -1.31% | -1.78% | |
| Form 10-Q GENELUX Corp For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -2.52% | -11.52% | |
| Form S-8 GENELUX Corp | SEC filing · Form S-8 | SEC EDGAR | -2.52% | -11.52% | |
| Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates | Press release | GlobeNewswire | -2.52% | -11.52% | |
| Form ARS GENELUX Corp For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -2.35% | +0.59% | |
| Form DEF 14A GENELUX Corp For: Jul 11 | SEC filing · Form DEF | SEC EDGAR | -2.35% | +0.59% | |
| Form DEFA14A GENELUX Corp | SEC filing · Form DEFA14A | SEC EDGAR | -2.35% | +0.59% | |
| Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development | Press release | GlobeNewswire | +5.36% | +3.57% | |
| Form 10-Q GENELUX Corp For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +3.35% | -2.93% | |
| Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates | Press release | GlobeNewswire | +3.35% | -2.93% | |
| Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference | Press release | GlobeNewswire | +3.70% | +8.23% | |
| Form 10-K/A GENELUX Corp For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +1.04% | -6.60% | |
| Form 10-K GENELUX Corp For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -4.33% | -10.00% | |
| Form S-8 GENELUX Corp | SEC filing · Form S-8 | SEC EDGAR | -4.33% | -10.00% | |
| Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update | Press release | GlobeNewswire | -4.33% | -10.00% | |
| Form 8-K GENELUX Corp For: Mar 25 | SEC filing · Form 8-K | SEC EDGAR | -0.70% | -2.86% | |
| Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer | Press release | GlobeNewswire | -0.70% | -2.86% | |
| Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease | Press release | GlobeNewswire | -0.70% | -2.86% | |
| Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock | Press release | GlobeNewswire | -0.70% | -2.86% | |
| Form 8-K GENELUX Corp For: Jan 29 | SEC filing · Form 8-K | SEC EDGAR | -10.11% | -0.84% | |
| Genelux Corporation Announces New Chief Financial Officer | Press release | GlobeNewswire | -10.11% | -0.84% | |
| Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright | Press release | GlobeNewswire | -0.39% | -9.34% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the GNLX section they belong to.
Where else GNLX is measured.
GNLX earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Genelux Corporation's median reaction calculated?
Every labeled GNLX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 247 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 41% of GNLX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does GNLX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.